1. | DayOneToday | |
2. | elitebio30 | |
3. | bensynergy | |
4. | BioTechBrains |
1. | DayOneToday | |
2. | elitebio30 | |
3. | bensynergy | |
4. | BioTechBrains |
1. | elitebio30 03/02/2018 NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs |
2. | bensynergy 10/05/2017 Never disclosed % patients PD-L1 positive. 53% of patients were treatment naive. 100% of patients treatment naive for checkpoints. |
3. | elitebio30 09/08/2017 @BioTechBrains Another great one for us! Did you listen to the Baird conf? |
4. | DayOneToday 04/17/2018 Presents poster at the AACR 2018 Annual Meeting |
5. | BioTechBrains 09/08/2017 Phase 2 updated data & presentation on 9th |
6. | elitebio30 07/02/2018 Announces positive updated Phase 1 data with indoximod plus radio-immunotherapy |